Understanding OR3A1: A Key Protein in The Sense of Smell (G4994)

Understanding OR3A1: A Key Protein in The Sense of Smell

OR3A1 (Olfactory Receptor Family 3 Subfamily A Member 1) is a protein that is expressed in the olfactory system, which is responsible for the sense of smell. OR3A1 is a G protein-coupled receptor (GPCR), which is a type of transmembrane protein that is involved in cell-signaling processes. OR3A1 is characterized by its extracellular domain, which is composed of a catalytic active center and a conserved helical domain.

OR3A1 is a key protein involved in the sense of smell, as it is responsible for the perception of olfactory information. Human beings have approximately 1.2 million olfactory neurons, which are located in the nasal cavity and are responsible for transmitting sensory information to the brain. Activation of these neurons can result in the sensation of smell, such as the smell of food, the smell of a flower, or the smell of smoke.

OR3A1 is a GPCR, which is a type of transmembrane protein that is involved in cell-signaling processes. GPCRs are a family of proteins that are characterized by their ability to transmit intracellular signals. OR3A1 is characterized by its extracellular domain, which is composed of a catalytic active center and a conserved helical domain.

The catalytic active center (CAC) of OR3A1 is a region that is involved in the chemical reaction that is responsible for the perception of smell. The CAC is composed of a nucleotide acid sequence that is specific for certain types of molecules, such as scents. When a scent binds to the CAC, it triggers a signaling cascade that results in the transmission of a signal to the brain.

OR3A1 is also characterized by its conserved helical domain (HSP). HSPs are regions of the protein that are involved in the formation of a specific conformation that is important for function. The HSP of OR3A1 is conserved across different species, which suggests that it plays an important role in the function of the olfactory system.

OR3A1 is a potential drug target (OR3A1-targeted) and a biomarker for various diseases, such as cancer, neurodegenerative diseases, and autoimmune diseases. For example, studies have shown that high levels of OR3A1 expression are associated with the development of certain types of cancer, such as breast cancer and ovarian cancer. Additionally, OR3A1 has also been shown to be involved in the development of neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease.

In addition to its potential clinical applications, OR3A1 is also a potential research tool for studying the molecular mechanisms of smell perception. For example, researchers can use genetic modifiers to knock down OR3A1 expression and study the impact on the sense of smell. Additionally, researchers can use techniques such as RNA interference and live cell imaging to study the role of OR3A1 in the olfactory system.

In conclusion, OR3A1 (Olfactory Receptor Family 3 Subfamily A Member 1) is a protein that is involved in the sense of smell and is a potential drug target and biomarker for various diseases. Its catalytic active center and conserved helical domain make it an attractive target for researchers to study the molecular mechanisms of smell perception. Further research is needed to fully understand the role of OR3A1 in the olfactory system and its potential as a therapeutic target.

Protein Name: Olfactory Receptor Family 3 Subfamily A Member 1

Functions: Odorant receptor

The "OR3A1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about OR3A1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

OR3A2 | OR3A3 | OR3A4P | OR4A14P | OR4A15 | OR4A16 | OR4A17P | OR4A21P | OR4A47 | OR4A5 | OR4B1 | OR4C11 | OR4C12 | OR4C13 | OR4C15 | OR4C16 | OR4C1P | OR4C3 | OR4C45 | OR4C46 | OR4C5 | OR4C50P | OR4C6 | OR4D1 | OR4D10 | OR4D11 | OR4D2 | OR4D5 | OR4D6 | OR4D9 | OR4E2 | OR4F13P | OR4F15 | OR4F16 | OR4F17 | OR4F21 | OR4F29 | OR4F3 | OR4F4 | OR4F5 | OR4F6 | OR4G3P | OR4K1 | OR4K13 | OR4K14 | OR4K15 | OR4K17 | OR4K2 | OR4K5 | OR4K6P | OR4K7P | OR4L1 | OR4M1 | OR4M2 | OR4M2-OT1 | OR4N2 | OR4N3P | OR4N4 | OR4N5 | OR4P4 | OR4Q3 | OR4S1 | OR4S2 | OR4T1P | OR4V1P | OR4X1 | OR4X2 | OR51A1P | OR51A2 | OR51A3P | OR51A4 | OR51A6P | OR51A7 | OR51B2 | OR51B4 | OR51B5 | OR51B6 | OR51C1P | OR51D1 | OR51E1 | OR51E2 | OR51F1 | OR51F2 | OR51G1 | OR51G2 | OR51H1 | OR51I1 | OR51I2 | OR51J1 | OR51L1 | OR51M1 | OR51Q1 | OR51S1 | OR51T1 | OR51V1 | OR52A1 | OR52A4P | OR52A5 | OR52B2 | OR52B4